Liquid biopsy tumour fraction, total tumour volume, and automated whole-body CT body composition for survival stratification in metastatic cancer: A temporally validated pan-cancer cohort study
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Liquid biopsy tumour fraction, total tumour volume, and automated whole-body CT body composition for survival stratification in metastatic cancer: A temporally validated pan-cancer cohort study. // European Journal of Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S0959804926008579?dgcid=rss_sd_all
Liquid biopsy tumour fraction, total tumour volume, and automated whole-body CT body composition for survival stratification in metastatic cancer: A temporally validated pan-cancer cohort study. European Journal of Cancer. https://www.sciencedirect.com/science/article/pii/S0959804926008579?dgcid=rss_sd_all
“Liquid biopsy tumour fraction, total tumour volume, and automated whole-body CT body composition for survival stratification in metastatic cancer: A temporally validated pan-cancer cohort study.” European Journal of Cancer.
@article{article45026,
title = {Liquid biopsy tumour fraction, total tumour volume, and automated whole-body CT body composition for survival stratification in metastatic cancer: A temporally validated pan-cancer cohort study},
journal = {European Journal of Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S0959804926008579?dgcid=rss_sd_all}
}